Tina Satterwhite, PhD, President, Pharmaceutical Development Services
Tina has the responsibility for the division’s operations and overall business leadership with oversight of both the Gaithersburg, Maryland and Ewing, New Jersey laboratories. Services provided at these sites include bioanalytical services that support the development of large molecule therapeutics from discovery through phase IV, with expertise in bioassays and ultra-sensitive ligand-binding assays.